Related Experiment Video
Updated: Jun 11, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
Biological agents for chronic wounds
1Department and Cutaneous Surgery, University of Miami Miller School of Medicine, 1600 N.W. 10th Avenue, RMSB, Room 2023-A, Miami, FL 33136, USA. rkirsner@med.miami.edu
Abstract:
Tumor necrosis factor alpha antagonists (e.g. etanercept) are now being extensively evaluated in the setting of chronic wound healing. Preliminary studies and case reports provide evidence of the clinical potential of these compounds in pyoderma gangrenosum, and further investigations are warranted. A clear rationale also exists for further detailed assessments of the potential efficacy of etanercept in patients with venous leg ulcers or hospital-acquired pressure ulcers.
Related Concept Videos
Chemical Agents for Microbial Control
Biological Methods for Microbial Control
Diabetic Foot Ulcer
Determinants of Bacterial Pathogenicity and Virulence
Hand hygiene
Hand washing...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
